ATM and lymphoma: Coherent with its role in checkpoint signaling and genome maintenance, ATM is frequently mutated in various human cancer entities, ranging from solid tumors to lymphomas and leukemias (Haidar et al., 2000; Ripolles et al., 2006; Ding et al., 2008; Waddell et al., 2015).